Study measuring radiation dose during brachytherapy
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a way to measure the exact radiation dose you receive during internal radiotherapy (brachytherapy). It aims to make treatment safer and more effective for prostate or gynecologic cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are getting high-dose-rate brachytherapy with iridium-192, alone or with external beam radiation.
- You have prostate cancer (new or returned) or certain gynecologic cancers (cervix, vulva, vaginal, or endometrial) at specific stages.
- You are well enough to have daily activities (performance status 0-2).
- You have not had brachytherapy to the same area before.
- You can give informed consent and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how safe and effective different high-dose radiation levels are for prostate cancer placed directly in the prostate (HDR brachytherapy). It may help by finding a dose that controls the cancer while keeping side effects acceptable.
This trial tests a new device that helps doctors deliver brachytherapy more accurately and safely by measuring the radiation dose in real time during treatment. It may lead to better outcomes for prostate or cervical cancer patients.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
This study tests whether giving a lower radiation dose to the vagina during brachytherapy (internal radiation) is safe and works as well as the standard dose for people with cervical cancer that has not spread to the vagina. It aims to reduce side effects while still treating the cancer effectively.
This study checks if doctors can better verify brachytherapy (a type of internal radiation) during treatment for gynecological or prostate cancer. It may help improve accuracy and outcomes for patients receiving this therapy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.